nodes	percent_of_prediction	percent_of_DWPC	metapath
Conivaptan—CYP3A4—Disulfiram—alcohol dependence	0.17	0.584	CbGbCtD
Conivaptan—CYP3A4—Citalopram—alcohol dependence	0.121	0.416	CbGbCtD
Conivaptan—Pharyngolaryngeal pain—Naltrexone—alcohol dependence	0.00869	0.0291	CcSEcCtD
Conivaptan—Laryngeal pain—Naltrexone—alcohol dependence	0.00861	0.0288	CcSEcCtD
Conivaptan—Urine output increased—Acamprosate—alcohol dependence	0.00561	0.0188	CcSEcCtD
Conivaptan—Pharyngolaryngeal pain—Citalopram—alcohol dependence	0.00551	0.0185	CcSEcCtD
Conivaptan—Laryngeal pain—Citalopram—alcohol dependence	0.00545	0.0183	CcSEcCtD
Conivaptan—Phlebitis—Acamprosate—alcohol dependence	0.00522	0.0175	CcSEcCtD
Conivaptan—Polyuria—Acamprosate—alcohol dependence	0.00513	0.0172	CcSEcCtD
Conivaptan—Phlebitis—Naltrexone—alcohol dependence	0.00494	0.0166	CcSEcCtD
Conivaptan—Thirst—Acamprosate—alcohol dependence	0.00473	0.0158	CcSEcCtD
Conivaptan—Cardiac failure—Acamprosate—alcohol dependence	0.00461	0.0155	CcSEcCtD
Conivaptan—Hyponatraemia—Acamprosate—alcohol dependence	0.00452	0.0151	CcSEcCtD
Conivaptan—Atrial fibrillation—Naltrexone—alcohol dependence	0.00449	0.0151	CcSEcCtD
Conivaptan—Thirst—Naltrexone—alcohol dependence	0.00447	0.015	CcSEcCtD
Conivaptan—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00411	0.0138	CcSEcCtD
Conivaptan—AVPR1A—endocrine gland—alcohol dependence	0.00407	0.156	CbGeAlD
Conivaptan—Dehydration—Naltrexone—alcohol dependence	0.00396	0.0133	CcSEcCtD
Conivaptan—Pain—Disulfiram—alcohol dependence	0.00384	0.0129	CcSEcCtD
Conivaptan—AVPR1A—liver—alcohol dependence	0.00367	0.141	CbGeAlD
Conivaptan—AVPR1A—central nervous system—alcohol dependence	0.00367	0.141	CbGeAlD
Conivaptan—Pollakiuria—Acamprosate—alcohol dependence	0.00359	0.012	CcSEcCtD
Conivaptan—Candida infection—Citalopram—alcohol dependence	0.00355	0.0119	CcSEcCtD
Conivaptan—Hyperglycaemia—Acamprosate—alcohol dependence	0.00351	0.0118	CcSEcCtD
Conivaptan—Pneumonia—Acamprosate—alcohol dependence	0.00349	0.0117	CcSEcCtD
Conivaptan—Urinary tract infection—Acamprosate—alcohol dependence	0.00337	0.0113	CcSEcCtD
Conivaptan—Urine output increased—Citalopram—alcohol dependence	0.00336	0.0113	CcSEcCtD
Conivaptan—Haematuria—Acamprosate—alcohol dependence	0.00331	0.0111	CcSEcCtD
Conivaptan—Pneumonia—Naltrexone—alcohol dependence	0.0033	0.0111	CcSEcCtD
Conivaptan—Infestation—Naltrexone—alcohol dependence	0.00328	0.011	CcSEcCtD
Conivaptan—Infestation NOS—Naltrexone—alcohol dependence	0.00328	0.011	CcSEcCtD
Conivaptan—Sepsis—Citalopram—alcohol dependence	0.00323	0.0108	CcSEcCtD
Conivaptan—Urinary tract infection—Naltrexone—alcohol dependence	0.00319	0.0107	CcSEcCtD
Conivaptan—AVPR2—nervous system—alcohol dependence	0.00316	0.121	CbGeAlD
Conivaptan—Phlebitis—Citalopram—alcohol dependence	0.00313	0.0105	CcSEcCtD
Conivaptan—Polyuria—Citalopram—alcohol dependence	0.00307	0.0103	CcSEcCtD
Conivaptan—Oedema peripheral—Acamprosate—alcohol dependence	0.00307	0.0103	CcSEcCtD
Conivaptan—AVPR2—central nervous system—alcohol dependence	0.00304	0.117	CbGeAlD
Conivaptan—AVPR1A—brain—alcohol dependence	0.00291	0.112	CbGeAlD
Conivaptan—Atrial fibrillation—Citalopram—alcohol dependence	0.00285	0.00954	CcSEcCtD
Conivaptan—Thirst—Citalopram—alcohol dependence	0.00284	0.0095	CcSEcCtD
Conivaptan—Headache—Disulfiram—alcohol dependence	0.00281	0.00943	CcSEcCtD
Conivaptan—Cardiac failure—Citalopram—alcohol dependence	0.00276	0.00926	CcSEcCtD
Conivaptan—Hypoglycaemia—Citalopram—alcohol dependence	0.00276	0.00926	CcSEcCtD
Conivaptan—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00276	0.00719	CbGpPWpGaD
Conivaptan—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00275	0.00716	CbGpPWpGaD
Conivaptan—Cardiac disorder—Naltrexone—alcohol dependence	0.00273	0.00916	CcSEcCtD
Conivaptan—Mental disorder—Acamprosate—alcohol dependence	0.00273	0.00914	CcSEcCtD
Conivaptan—Malnutrition—Acamprosate—alcohol dependence	0.00271	0.00908	CcSEcCtD
Conivaptan—Hyponatraemia—Citalopram—alcohol dependence	0.00271	0.00908	CcSEcCtD
Conivaptan—Angiopathy—Naltrexone—alcohol dependence	0.00267	0.00896	CcSEcCtD
Conivaptan—Mediastinal disorder—Naltrexone—alcohol dependence	0.00265	0.0089	CcSEcCtD
Conivaptan—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00262	0.00682	CbGpPWpGaD
Conivaptan—Mental disorder—Naltrexone—alcohol dependence	0.00258	0.00865	CcSEcCtD
Conivaptan—Malnutrition—Naltrexone—alcohol dependence	0.00256	0.00859	CcSEcCtD
Conivaptan—Dehydration—Citalopram—alcohol dependence	0.00251	0.00841	CcSEcCtD
Conivaptan—Anaemia—Acamprosate—alcohol dependence	0.00251	0.0084	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00248	0.00645	CbGpPWpGaD
Conivaptan—Orthostatic hypotension—Citalopram—alcohol dependence	0.00246	0.00826	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00246	0.0064	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—HTR7—alcohol dependence	0.00246	0.0064	CbGpPWpGaD
Conivaptan—Hypokalaemia—Citalopram—alcohol dependence	0.00246	0.00823	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00243	0.00633	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.00242	0.00629	CbGpPWpGaD
Conivaptan—AVPR2—brain—alcohol dependence	0.00241	0.0926	CbGeAlD
Conivaptan—AVPR1A—GPCR ligand binding—OPRK1—alcohol dependence	0.0024	0.00626	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—OPRK1—alcohol dependence	0.00239	0.00621	CbGpPWpGaD
Conivaptan—Hypertension—Acamprosate—alcohol dependence	0.00234	0.00784	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00229	0.00768	CcSEcCtD
Conivaptan—Dry mouth—Acamprosate—alcohol dependence	0.00226	0.00756	CcSEcCtD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00224	0.00583	CbGpPWpGaD
Conivaptan—Confusional state—Acamprosate—alcohol dependence	0.00223	0.00747	CcSEcCtD
Conivaptan—AVPR2—Peptide ligand-binding receptors—NPY—alcohol dependence	0.00222	0.00579	CbGpPWpGaD
Conivaptan—Hypertension—Naltrexone—alcohol dependence	0.00221	0.00742	CcSEcCtD
Conivaptan—Infection—Acamprosate—alcohol dependence	0.0022	0.00736	CcSEcCtD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00217	0.00727	CcSEcCtD
Conivaptan—Pollakiuria—Citalopram—alcohol dependence	0.00215	0.00722	CcSEcCtD
Conivaptan—Skin disorder—Acamprosate—alcohol dependence	0.00215	0.0072	CcSEcCtD
Conivaptan—Dry mouth—Naltrexone—alcohol dependence	0.00214	0.00716	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00212	0.00552	CbGpPWpGaD
Conivaptan—Confusional state—Naltrexone—alcohol dependence	0.00211	0.00707	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.00211	0.00548	CbGpPWpGaD
Conivaptan—Hyperglycaemia—Citalopram—alcohol dependence	0.0021	0.00705	CcSEcCtD
Conivaptan—Pneumonia—Citalopram—alcohol dependence	0.00209	0.00701	CcSEcCtD
Conivaptan—Infection—Naltrexone—alcohol dependence	0.00208	0.00697	CcSEcCtD
Conivaptan—Infestation NOS—Citalopram—alcohol dependence	0.00208	0.00697	CcSEcCtD
Conivaptan—Infestation—Citalopram—alcohol dependence	0.00208	0.00697	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00208	0.0054	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—AVP—alcohol dependence	0.00207	0.00538	CbGpPWpGaD
Conivaptan—Hypotension—Acamprosate—alcohol dependence	0.00207	0.00693	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.00206	0.00536	CbGpPWpGaD
Conivaptan—Nervous system disorder—Naltrexone—alcohol dependence	0.00205	0.00688	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00203	0.00529	CbGpPWpGaD
Conivaptan—Skin disorder—Naltrexone—alcohol dependence	0.00203	0.00681	CcSEcCtD
Conivaptan—Urinary tract infection—Citalopram—alcohol dependence	0.00202	0.00677	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00202	0.00526	CbGpPWpGaD
Conivaptan—Insomnia—Acamprosate—alcohol dependence	0.002	0.0067	CcSEcCtD
Conivaptan—Haematuria—Citalopram—alcohol dependence	0.00198	0.00664	CcSEcCtD
Conivaptan—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00194	0.00505	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00191	0.0064	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00191	0.00496	CbGpPWpGaD
Conivaptan—Insomnia—Naltrexone—alcohol dependence	0.00189	0.00634	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.00189	0.00492	CbGpPWpGaD
Conivaptan—Constipation—Acamprosate—alcohol dependence	0.00189	0.00634	CcSEcCtD
Conivaptan—Pain—Acamprosate—alcohol dependence	0.00189	0.00634	CcSEcCtD
Conivaptan—Urinary tract disorder—Citalopram—alcohol dependence	0.00184	0.00618	CcSEcCtD
Conivaptan—Oedema peripheral—Citalopram—alcohol dependence	0.00184	0.00616	CcSEcCtD
Conivaptan—Urethral disorder—Citalopram—alcohol dependence	0.00183	0.00613	CcSEcCtD
Conivaptan—Feeling abnormal—Acamprosate—alcohol dependence	0.00182	0.00611	CcSEcCtD
Conivaptan—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.00181	0.00606	CcSEcCtD
Conivaptan—Pain—Naltrexone—alcohol dependence	0.00179	0.006	CcSEcCtD
Conivaptan—Constipation—Naltrexone—alcohol dependence	0.00179	0.006	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00178	0.00463	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.00177	0.00459	CbGpPWpGaD
Conivaptan—Body temperature increased—Acamprosate—alcohol dependence	0.00175	0.00586	CcSEcCtD
Conivaptan—Cardiac disorder—Citalopram—alcohol dependence	0.00173	0.00581	CcSEcCtD
Conivaptan—Feeling abnormal—Naltrexone—alcohol dependence	0.00172	0.00578	CcSEcCtD
Conivaptan—Angiopathy—Citalopram—alcohol dependence	0.00169	0.00568	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00169	0.0044	CbGpPWpGaD
Conivaptan—Mediastinal disorder—Citalopram—alcohol dependence	0.00168	0.00564	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.00168	0.00437	CbGpPWpGaD
Conivaptan—Body temperature increased—Naltrexone—alcohol dependence	0.00165	0.00554	CcSEcCtD
Conivaptan—Mental disorder—Citalopram—alcohol dependence	0.00164	0.00548	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00163	0.00425	CbGpPWpGaD
Conivaptan—Malnutrition—Citalopram—alcohol dependence	0.00162	0.00545	CcSEcCtD
Conivaptan—Erythema—Citalopram—alcohol dependence	0.00162	0.00545	CcSEcCtD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00162	0.00422	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—OPRD1—alcohol dependence	0.00162	0.00421	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—OPRD1—alcohol dependence	0.0016	0.00418	CbGpPWpGaD
Conivaptan—Pruritus—Acamprosate—alcohol dependence	0.00157	0.00524	CcSEcCtD
Conivaptan—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00155	0.00403	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—PDYN—alcohol dependence	0.00155	0.00403	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—PDYN—alcohol dependence	0.00154	0.004	CbGpPWpGaD
Conivaptan—Diarrhoea—Acamprosate—alcohol dependence	0.00151	0.00507	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.0015	0.00391	CbGpPWpGaD
Conivaptan—Anaemia—Citalopram—alcohol dependence	0.0015	0.00503	CcSEcCtD
Conivaptan—AVPR1A—G alpha (q) signalling events—AVP—alcohol dependence	0.0015	0.0039	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00149	0.00388	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—AVP—alcohol dependence	0.00148	0.00385	CbGpPWpGaD
Conivaptan—Pruritus—Naltrexone—alcohol dependence	0.00148	0.00496	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00148	0.00385	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00148	0.00384	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—AVP—alcohol dependence	0.00147	0.00383	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.00147	0.00382	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.00146	0.0038	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00145	0.00377	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CRHR1—alcohol dependence	0.00144	0.00375	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00144	0.00375	CbGpPWpGaD
Conivaptan—Diarrhoea—Naltrexone—alcohol dependence	0.00143	0.0048	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—CRHR1—alcohol dependence	0.00143	0.00372	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.00141	0.00368	CbGpPWpGaD
Conivaptan—Vomiting—Acamprosate—alcohol dependence	0.00141	0.00471	CcSEcCtD
Conivaptan—Hypertension—Citalopram—alcohol dependence	0.0014	0.0047	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.0014	0.00365	CbGpPWpGaD
Conivaptan—Headache—Acamprosate—alcohol dependence	0.00139	0.00464	CcSEcCtD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.00138	0.00359	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.00138	0.00359	CbGpPWpGaD
Conivaptan—AVPR2—G alpha (s) signalling events—POMC—alcohol dependence	0.00137	0.00358	CbGpPWpGaD
Conivaptan—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00137	0.0046	CcSEcCtD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.00137	0.00356	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.00137	0.00356	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—OPRK1—alcohol dependence	0.00136	0.00354	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CHRM2—alcohol dependence	0.00135	0.00352	CbGpPWpGaD
Conivaptan—Dry mouth—Citalopram—alcohol dependence	0.00135	0.00453	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—OPRK1—alcohol dependence	0.00135	0.00351	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CHRM2—alcohol dependence	0.00134	0.0035	CbGpPWpGaD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.00134	0.00349	CbGpPWpGaD
Conivaptan—Confusional state—Citalopram—alcohol dependence	0.00134	0.00448	CcSEcCtD
Conivaptan—Vomiting—Naltrexone—alcohol dependence	0.00133	0.00446	CcSEcCtD
Conivaptan—Infection—Citalopram—alcohol dependence	0.00132	0.00441	CcSEcCtD
Conivaptan—Nausea—Acamprosate—alcohol dependence	0.00131	0.0044	CcSEcCtD
Conivaptan—Headache—Naltrexone—alcohol dependence	0.00131	0.00439	CcSEcCtD
Conivaptan—Nervous system disorder—Citalopram—alcohol dependence	0.0013	0.00436	CcSEcCtD
Conivaptan—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.0013	0.00337	CbGpPWpGaD
Conivaptan—Skin disorder—Citalopram—alcohol dependence	0.00129	0.00432	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.00127	0.0033	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.00126	0.00327	CbGpPWpGaD
Conivaptan—AVPR1A—G alpha (q) signalling events—HTR2A—alcohol dependence	0.00125	0.00325	CbGpPWpGaD
Conivaptan—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00125	0.00325	CbGpPWpGaD
Conivaptan—Nausea—Naltrexone—alcohol dependence	0.00124	0.00417	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—OPRM1—alcohol dependence	0.00124	0.00324	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.00124	0.00323	CbGpPWpGaD
Conivaptan—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00124	0.00323	CbGpPWpGaD
Conivaptan—Hypotension—Citalopram—alcohol dependence	0.00124	0.00415	CcSEcCtD
Conivaptan—AVPR2—GPCR ligand binding—OPRM1—alcohol dependence	0.00123	0.00321	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—OPRK1—alcohol dependence	0.00123	0.00321	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OPRK1—alcohol dependence	0.00122	0.00319	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00122	0.00318	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.00121	0.00315	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.0012	0.00313	CbGpPWpGaD
Conivaptan—Insomnia—Citalopram—alcohol dependence	0.0012	0.00402	CcSEcCtD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00118	0.00307	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00118	0.00307	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.00117	0.00305	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.00117	0.00305	CbGpPWpGaD
Conivaptan—Gastrointestinal disorder—Citalopram—alcohol dependence	0.00114	0.00384	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—NPY—alcohol dependence	0.00114	0.00298	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—NPY—alcohol dependence	0.00114	0.00296	CbGpPWpGaD
Conivaptan—Pain—Citalopram—alcohol dependence	0.00113	0.0038	CcSEcCtD
Conivaptan—Constipation—Citalopram—alcohol dependence	0.00113	0.0038	CcSEcCtD
Conivaptan—AVPR1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.00112	0.00291	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR1B—alcohol dependence	0.0011	0.00287	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—CRH—alcohol dependence	0.0011	0.00287	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CRH—alcohol dependence	0.0011	0.00285	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR1B—alcohol dependence	0.0011	0.00285	CbGpPWpGaD
Conivaptan—Feeling abnormal—Citalopram—alcohol dependence	0.00109	0.00366	CcSEcCtD
Conivaptan—Body temperature increased—Citalopram—alcohol dependence	0.00105	0.00351	CcSEcCtD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00104	0.00271	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000993	0.00259	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000986	0.00257	CbGpPWpGaD
Conivaptan—AVPR1A—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000984	0.00256	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.00098	0.00255	CbGpPWpGaD
Conivaptan—AVPR2—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000977	0.00254	CbGpPWpGaD
Conivaptan—AVPR1A—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000965	0.00251	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—DRD4—alcohol dependence	0.000965	0.00251	CbGpPWpGaD
Conivaptan—AVPR2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000958	0.00249	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—DRD4—alcohol dependence	0.000958	0.00249	CbGpPWpGaD
Conivaptan—Pruritus—Citalopram—alcohol dependence	0.000938	0.00314	CcSEcCtD
Conivaptan—AVPR1A—GPCR ligand binding—CNR1—alcohol dependence	0.000921	0.0024	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—CNR1—alcohol dependence	0.000915	0.00238	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—OPRD1—alcohol dependence	0.000913	0.00238	CbGpPWpGaD
Conivaptan—Diarrhoea—Citalopram—alcohol dependence	0.000907	0.00304	CcSEcCtD
Conivaptan—AVPR2—GPCR downstream signaling—OPRD1—alcohol dependence	0.000907	0.00236	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—DRD2—alcohol dependence	0.000899	0.00234	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR7—alcohol dependence	0.000899	0.00234	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—DRD2—alcohol dependence	0.000892	0.00232	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR7—alcohol dependence	0.000892	0.00232	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000884	0.0023	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—PDYN—alcohol dependence	0.000875	0.00228	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—PDYN—alcohol dependence	0.000869	0.00226	CbGpPWpGaD
Conivaptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000848	0.00221	CbGpPWpGaD
Conivaptan—Vomiting—Citalopram—alcohol dependence	0.000843	0.00283	CcSEcCtD
Conivaptan—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000833	0.00217	CbGpPWpGaD
Conivaptan—Headache—Citalopram—alcohol dependence	0.000831	0.00278	CcSEcCtD
Conivaptan—AVPR1A—Signaling by GPCR—OPRD1—alcohol dependence	0.000829	0.00216	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000827	0.00215	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OPRD1—alcohol dependence	0.000823	0.00214	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000821	0.00214	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CRHR1—alcohol dependence	0.000814	0.00212	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CRHR1—alcohol dependence	0.000808	0.0021	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—PDYN—alcohol dependence	0.000795	0.00207	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—PDYN—alcohol dependence	0.000789	0.00205	CbGpPWpGaD
Conivaptan—Nausea—Citalopram—alcohol dependence	0.000788	0.00264	CcSEcCtD
Conivaptan—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000784	0.00204	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000775	0.00202	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CHRM2—alcohol dependence	0.000765	0.00199	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CHRM2—alcohol dependence	0.00076	0.00198	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—AVP—alcohol dependence	0.000756	0.00197	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—AVP—alcohol dependence	0.000751	0.00195	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CRHR1—alcohol dependence	0.000739	0.00192	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CRHR1—alcohol dependence	0.000734	0.00191	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OPRK1—alcohol dependence	0.000729	0.0019	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OPRK1—alcohol dependence	0.000724	0.00188	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	0.000703	0.00183	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—OPRM1—alcohol dependence	0.000703	0.00183	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—OPRM1—alcohol dependence	0.000697	0.00182	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CHRM2—alcohol dependence	0.000695	0.00181	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CHRM2—alcohol dependence	0.00069	0.0018	CbGpPWpGaD
Conivaptan—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000666	0.00173	CbGpPWpGaD
Conivaptan—AVPR1A—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.00066	0.00172	CbGpPWpGaD
Conivaptan—AVPR2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000655	0.00171	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000649	0.00169	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—NPY—alcohol dependence	0.000647	0.00168	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000642	0.00167	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—NPY—alcohol dependence	0.000642	0.00167	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—OPRM1—alcohol dependence	0.000638	0.00166	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—OPRM1—alcohol dependence	0.000633	0.00165	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—HTR2A—alcohol dependence	0.000629	0.00164	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—HTR2A—alcohol dependence	0.000625	0.00163	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CRH—alcohol dependence	0.000624	0.00162	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR1B—alcohol dependence	0.000624	0.00162	CbGpPWpGaD
Conivaptan—CYP3A4—digestive system—alcohol dependence	0.000622	0.0238	CbGeAlD
Conivaptan—AVPR2—GPCR downstream signaling—HTR1B—alcohol dependence	0.000619	0.00161	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CRH—alcohol dependence	0.000619	0.00161	CbGpPWpGaD
Conivaptan—CYP3A4—blood—alcohol dependence	0.000592	0.0227	CbGeAlD
Conivaptan—AVPR1A—Signaling by GPCR—NPY—alcohol dependence	0.000587	0.00153	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—NPY—alcohol dependence	0.000583	0.00152	CbGpPWpGaD
Conivaptan—AVPR2—Transmembrane transport of small molecules—AVP—alcohol dependence	0.000581	0.00151	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR1B—alcohol dependence	0.000566	0.00147	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—CRH—alcohol dependence	0.000566	0.00147	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR1B—alcohol dependence	0.000562	0.00146	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CRH—alcohol dependence	0.000562	0.00146	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000552	0.00144	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000546	0.00142	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—DRD4—alcohol dependence	0.000545	0.00142	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—DRD4—alcohol dependence	0.000541	0.00141	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000538	0.0014	CbGpPWpGaD
Conivaptan—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000531	0.00138	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—CNR1—alcohol dependence	0.000521	0.00136	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—CNR1—alcohol dependence	0.000517	0.00135	CbGpPWpGaD
Conivaptan—CYP3A4—endocrine gland—alcohol dependence	0.000514	0.0197	CbGeAlD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR7—alcohol dependence	0.000508	0.00132	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—DRD2—alcohol dependence	0.000508	0.00132	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR7—alcohol dependence	0.000504	0.00131	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—DRD2—alcohol dependence	0.000504	0.00131	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR ligand binding—POMC—alcohol dependence	0.000503	0.00131	CbGpPWpGaD
Conivaptan—AVPR2—GPCR ligand binding—POMC—alcohol dependence	0.000499	0.0013	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—DRD4—alcohol dependence	0.000495	0.00129	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—DRD4—alcohol dependence	0.000492	0.00128	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OPRD1—alcohol dependence	0.00049	0.00127	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OPRD1—alcohol dependence	0.000486	0.00127	CbGpPWpGaD
Conivaptan—CYP3A4—nervous system—alcohol dependence	0.000481	0.0184	CbGeAlD
Conivaptan—AVPR1A—Signaling by GPCR—CNR1—alcohol dependence	0.000473	0.00123	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—PDYN—alcohol dependence	0.00047	0.00122	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000469	0.00122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—CNR1—alcohol dependence	0.000469	0.00122	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—PDYN—alcohol dependence	0.000466	0.00121	CbGpPWpGaD
Conivaptan—CYP3A4—liver—alcohol dependence	0.000463	0.0178	CbGeAlD
Conivaptan—CYP3A4—central nervous system—alcohol dependence	0.000463	0.0178	CbGeAlD
Conivaptan—AVPR1A—Signaling by GPCR—HTR7—alcohol dependence	0.000461	0.0012	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—DRD2—alcohol dependence	0.000461	0.0012	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR7—alcohol dependence	0.000458	0.00119	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—DRD2—alcohol dependence	0.000458	0.00119	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.00045	0.00117	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CRHR1—alcohol dependence	0.000437	0.00114	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—WASF2—alcohol dependence	0.000437	0.00114	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000436	0.00114	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—WASF2—alcohol dependence	0.000433	0.00113	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CRHR1—alcohol dependence	0.000433	0.00113	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—AVP—alcohol dependence	0.000428	0.00111	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—AVP—alcohol dependence	0.000424	0.0011	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—WASF1—alcohol dependence	0.000419	0.00109	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—WASF1—alcohol dependence	0.000416	0.00108	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000412	0.00107	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CHRM2—alcohol dependence	0.00041	0.00107	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CHRM2—alcohol dependence	0.000408	0.00106	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—AVP—alcohol dependence	0.000388	0.00101	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—AVP—alcohol dependence	0.000385	0.001	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—OPRM1—alcohol dependence	0.000377	0.000981	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—OPRM1—alcohol dependence	0.000374	0.000974	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000359	0.000935	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—HTR2A—alcohol dependence	0.000356	0.000926	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—HTR2A—alcohol dependence	0.000353	0.000919	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—NPY—alcohol dependence	0.000347	0.000903	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—NPY—alcohol dependence	0.000344	0.000896	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000341	0.000888	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR1B—alcohol dependence	0.000335	0.000871	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CRH—alcohol dependence	0.000335	0.000871	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR1B—alcohol dependence	0.000332	0.000865	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CRH—alcohol dependence	0.000332	0.000865	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—HTR2A—alcohol dependence	0.000323	0.000841	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—HTR2A—alcohol dependence	0.000321	0.000835	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DRD4—alcohol dependence	0.000292	0.000761	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—DRD4—alcohol dependence	0.00029	0.000756	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.00029	0.000755	CbGpPWpGaD
Conivaptan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000288	0.000751	CbGpPWpGaD
Conivaptan—AVPR1A—GPCR downstream signaling—POMC—alcohol dependence	0.000284	0.000739	CbGpPWpGaD
Conivaptan—AVPR2—GPCR downstream signaling—POMC—alcohol dependence	0.000282	0.000734	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—CNR1—alcohol dependence	0.000279	0.000727	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—CNR1—alcohol dependence	0.000277	0.000722	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR7—alcohol dependence	0.000272	0.000709	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—DRD2—alcohol dependence	0.000272	0.000709	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR7—alcohol dependence	0.000271	0.000704	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—DRD2—alcohol dependence	0.000271	0.000704	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling by GPCR—POMC—alcohol dependence	0.000258	0.000671	CbGpPWpGaD
Conivaptan—AVPR2—Signaling by GPCR—POMC—alcohol dependence	0.000256	0.000667	CbGpPWpGaD
Conivaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000234	0.000608	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000232	0.000603	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—AVP—alcohol dependence	0.000229	0.000597	CbGpPWpGaD
Conivaptan—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000229	0.000595	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—AVP—alcohol dependence	0.000228	0.000593	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000213	0.000554	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—HTR2A—alcohol dependence	0.000191	0.000497	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000191	0.000496	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—HTR2A—alcohol dependence	0.000189	0.000493	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—POMC—alcohol dependence	0.000152	0.000397	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—POMC—alcohol dependence	0.000151	0.000394	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADH6—alcohol dependence	0.000134	0.000349	CbGpPWpGaD
Conivaptan—CYP3A4—Biological oxidations—POMC—alcohol dependence	0.000124	0.000323	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADH1A—alcohol dependence	0.000111	0.000289	CbGpPWpGaD
Conivaptan—AVPR1A—Signaling Pathways—EP300—alcohol dependence	0.000101	0.000263	CbGpPWpGaD
Conivaptan—AVPR2—Signaling Pathways—EP300—alcohol dependence	0.0001	0.000261	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADH4—alcohol dependence	9.44e-05	0.000246	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADH7—alcohol dependence	8.03e-05	0.000209	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GGT2—alcohol dependence	7.7e-05	0.0002	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ADH1B—alcohol dependence	7.04e-05	0.000183	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MAOB—alcohol dependence	5.83e-05	0.000152	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—ALDH2—alcohol dependence	4.96e-05	0.000129	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT2—alcohol dependence	4.22e-05	0.00011	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.96e-05	0.000103	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GOT1—alcohol dependence	3.64e-05	9.47e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—GGT1—alcohol dependence	3.64e-05	9.47e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—MAOA—alcohol dependence	3.26e-05	8.49e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—POMC—alcohol dependence	2.12e-05	5.53e-05	CbGpPWpGaD
Conivaptan—CYP3A4—Metabolism—EP300—alcohol dependence	1.41e-05	3.67e-05	CbGpPWpGaD
